Search

Author/Creator Seidl, Andreas

1. Characterization and non-clinical assessment of the proposed etanercept biosimilar GP2015 with originator etanercept (Enbrel®). (2nd October 2016)

Authors:
Hofmann, Hans-Peter; Kronthaler, Ulrich; Fritsch, Cornelius; Grau, Roger; Müller, Stefan O.; Mayer, Robert; Seidl, Andreas; Da Silva, Antonio
Journal:
Expert opinion on biological therapy
Issue:
Volume 16:Number 10(2016:Oct.)
Page Start:
1185
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Non‐clinical Pharmacological Characterization and In‐Vivo Efficacy of the Proposed Adalimumab Biosimilar GP2017 Compared to the Originator Adalimumab: 617. (October 2016)

Authors:
da Silva, Antonio; Fritsch, Cornelius; Kronthaler, Ulrich; Hofmann, Hans‐Peter; Hainzl, Otmar; Seidl, Andreas
Journal:
American journal of gastroenterology
Issue:
Volume 111(2016)Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Shedding of glycan‐modifying enzymes by signal peptide peptidase‐like 3 (SPPL3) regulates cellular N‐glycosylation. (29th October 2014)

Authors:
Voss, Matthias; Künzel, Ulrike; Higel, Fabian; Kuhn, Peer‐Hendrik; Colombo, Alessio; Fukumori, Akio; Haug‐Kröper, Martina; Klier, Bärbel; Grammer, Gudula; Seidl, Andreas; Schröder, Bernd; Obst, Reinhard; Steiner, Harald; Lichtenthaler, Stefan F; Haass, Christian; Fluhrer, Regina
Journal:
EMBO journal
Issue:
Volume 33:Number 24(2014)
Page Start:
2890
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗